Physician profile
Joseph Mitchell
NPI 1699161471
$17,591.21
in general payments reported to CMS, 2019-2025
9 companies · $8,138 in 2025
The $8,138 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,182 · 2021: $555 · 2022: $2,275 · 2023: $1,021 · 2024: $4,420 · 2025: $8,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,924 · Food and Beverage: $3,972 · Travel and Lodging: $544 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,923.57 |
| Food and Beverage | $3,971.70 |
| Travel and Lodging | $543.74 |
| Education | $139.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $9,272.77 | 2020-2025 | Velys, Attune |
| Stryker Corporation | $3,852.61 | 2020-2025 | Mako |
| Zimmer Biomet Holdings, INC. | $2,313.49 | 2020-2025 | Persona, Mymobility Platform, Osseoti Reconstructive System |
| Globus Medical, INC. | $1,494.45 | 2021-2025 | Excelsiusgps Robotic Navigation System, Onvoy, Actify |
| Depuy Synthes Sales INC. | $381.36 | 2021-2024 | Actis |
| Biocomposites INC | $128.01 | 2025 | Stimulan |
| Heraeus Medical, LLC. | $107.65 | 2022 | |
| Bioventus LLC | $21.57 | 2024 | Supartz Fx Sodium Hyaluronate |
| Organogenesis INC. | $19.30 | 2025 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.